Suthe’s DigiVibe device offers a solution for individuals undergoing fertility treatments by reducing the pain associated with hormone injections. The handheld device uses vibration technology to block pain signals before they reach the brain.
For fertility patients requiring multiple daily hormone injections during IVF cycles, this technology addresses both physical discomfort and anxiety. The device works on the Pain Gate Theory principle, delivering micro-pulses that interrupt pain transmission.
“Our mission is to enhance the quality of life for individuals requiring regular injections by providing innovative solutions that reduce discomfort and anxiety,” said Mark Lorberbaum, Founder & CEO at Suthe.
The cordless, ergonomic device requires no charging and is designed for portability, allowing fertility patients to maintain their injection schedules regardless of location. The company claims the device is clinically proven to reduce injection pain across various procedure types.
The standard device includes the DigiVibe unit, a lancing device, sonic tip, and battery. While this represents an additional cost for fertility patients, the potential comfort benefits may be valuable for those facing numerous injections throughout treatment cycles.
